drugs

A Partial Approval for Amgen's Osteoporosis Drug - New York Times
dBTechnoA Partial Approval for Amgen's Osteoporosis DrugNew York TimesAmgen's new bone drug, the company's best hope for future growth, won a partial endorsement Thursday from a federal advisory committee ...Analysts reaffirm high hopes for Amgen bone drugForbesAmgen presses US panel to endorse key bone drugReutersNew osteoporosis drug shown to reduce spinal fracturesLos Angeles TimesBusinessWeek�-BioWorld Online�-Forbesall 795 news articles��